Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2025	Apr. 30, 2025
Current assets:
Cash and cash equivalents	$ 11,659	$ 6,715
Accounts receivable, net	1,100	1,191
Contract assets	752	1,088
Inventory	4,694	4,222
Other current assets	722	400
Total current assets	18,927	13,616
Property and equipment, net	5,863	3,444
Intangibles, net	3,423	3,490
Right-of-use assets, net	2,414	1,552
Restricted cash, long-term	154	154
Goodwill	8,537	8,537
Total assets	39,318	30,793
Current liabilities:
Accounts payable	1,436	568
Earnout payable	200	300
Convertible notes payable (Note 13)	10,251
Derivative liability (Note 13)	881
Accrued expenses	1,318	1,271
Right-of-use liabilities, current portion	1,140	1,150
Contract liabilities	135
Total current liabilities	15,361	3,289
Deferred tax liability	203	203
Right-of-use liabilities, less current portion	1,455	649
Total liabilities	17,019	4,141
Commitments and contingencies (Note 14)
Shareholders’ Equity:
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding; 100,000 designated as Series A
Common stock, $0.001 par value; authorized 300,000,000 shares, issued 189,777,289 shares and 189,050,563 shares respectively; outstanding 188,989,809 shares and 171,263,086 shares, respectively	190	172
Treasury stock, at cost; 787,477 and 787,477 shares, respectively	(1,018)	(1,018)
Additional paid-in capital	370,429	356,588
Accumulated deficit	(347,302)	(329,090)
Accumulated other comprehensive loss
Total shareholders’ equity	22,299	26,652
Total liabilities and shareholders’ equity	$ 39,318	$ 30,793